(Q35083630)

6 August 2017

title

Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes (English)

1 reference

6 August 2017

0 references

1 reference

Diana Campioni

0 references

Silvano Capitani

0 references

Paola Secchiero

0 references

Federica Corallini

1 reference

6 August 2017

Elisabetta Melloni

series ordinal

1 reference

6 August 2017

Francesco Lanza

series ordinal

1 reference

6 August 2017

Giorgio Zauli

series ordinal

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

The American Journal of Pathology

6 August 2017

published in

1 reference

6 August 2017

volume

166

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

557-563

1 reference

Btk is required for an efficient response to erythropoietin and for SCF-controlled protection against TRAIL in erythroid progenitors.

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Apo2L/TRAIL and its death and decoy receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

World Health Organization classification of the acute leukemias and myelodysplastic syndrome.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Safety and antitumor activity of recombinant soluble Apo2 ligand

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Identification and characterization of a new member of the TNF family that induces apoptosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

TRAIL regulates normal erythroid maturation through an ERK-dependent pathway

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602326

Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

27 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

Marrow stroma in MDS: culprit or bystander?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

Negative regulation of erythropoiesis by caspase-mediated cleavage of GATA-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2962277-8

Intramedullary apoptosis of hematopoietic cells in myelodysplastic syndrome patients can be massive: apoptotic cells recovered from high-density fraction of bone marrow aspirates

7 January 2021

1 reference

12 December 2020

Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes

1 reference

12 December 2020

Apoptosis in bone marrow of myelodysplastic syndrome patients

1 reference

12 December 2020

The relative extent and propensity of CD34+ vs. CD34- cells to undergo apoptosis in myelodysplastic marrows

1 reference

12 December 2020

1 reference

12 December 2020

10.1016/S0002-9440(10)62277-8

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference